Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Schedule
Home
Poster Schedule
All Days
Mon, Oct 23
Tue, Oct 24
Wed, Oct 25
Poster Schedule
Type here to filter the list
Wednesday, October 25, 2023
9:30 AM – 10:30 AM
ET
(W0930-01-01) Targeting TNBC Tumor Using Hypoxia-Responsive Nanoparticles containing Synergistic Drug Combinations
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-02) Physical Stability of an Excipient System – How to Approach This Critical Performance Parameter?
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-03) Developing a Platform for Formulation Screening of High Concentration Monoclonal Antibodies (mAbs)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-04) Fabrication and Characterization of Amlodipine Besylate Based Sub-cutaneous Implants: Fabricated with the Help of Hot Melt Extrusion
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-05) Assessment of Phenol and Benzyl Alcohol for Use as Preservatives in mAb Drug Therapies
Favorite
9:30 AM – 10:30 AM
ET
(W0930-01-06) Intranasal Delivery of pApoE to the Brain for Developing Effective Therapeutics for Alzheimer’s disease
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-08) Bupivacaine Hydrochloride Mucoadhesive In Situ Forming Gels for Oral Mucositis: Physiological Considerations
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-09) Development of a Sustained Transdermal Delivery System of Amiloride for Management of Resistant Hypertension
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-10) Evaluation of the Effect of the Backing Layer Formulation on Dissolvable Microneedle Properties
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-11) Influence of Coating Parameters on Uniformity and Yield of Immediate Release Coating Formulation of a Low Dose Drug (Linagliptin) onto Metformin HCl ER Tablets - Fixed Dose Combination
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-12) Orodispersible Minitablets with Taste-Masked Spray-Dried Dispersions: Tablet Compression and Electronic Tongue Assessment
Favorite
9:30 AM – 10:30 AM
ET
(W0930-02-13) Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-15) Oral Delivery of Probiotics Using Delayed-Release Capsules: Formulation and Dosage Form Considerations
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-16) Development of Metformin HCL Sprinkles for Pediatric Oral Administration Using Hot-Melt Extrusion
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-17) Development of Soluplus/TPGS Mixed Micelles Using Hot-Melt Extrusion for Hydrophobic Drug Delivery
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-18) Impact of Formulation Composition, Lyophilization Processing Parameters and Freeze Dryer Configuration on Appearance of Lyophilized Finished Product
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-19) Improved Distribution of Water Insoluble Components in Soluble Thin Film Formulations
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-20) In Vitro Evaluation of Two Morphine Sulfate Extended-Release Products Sprinkled on Soft Foods
Favorite
9:30 AM – 10:30 AM
ET
(W0930-03-21) Dispersome
®
a Viable Alternative toward Enhanced Drug Load and Bioavailability
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-23) In Vitro Synergism of Depolymerase-Antibiotic Combination against Multidrug-Resistant
Acinetobacter baumannii
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-25) Physiologically Based Pharmacokinetic (PBPK) Oral Absorption Model to Predict Mucosal Permeability of Oral Cavity Drug Products
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-26) A Novel Poly(N-isopropylacrylamide)-based Thermoresponsive Bioink for DLP Bioprinting
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-27) Novel Blood Pressure Lowering Effects of Statins
Favorite
9:30 AM – 10:30 AM
ET
(W0930-04-28) Enhanced Cytotoxic Effect of Paclitaxel in Combination with Calcipotriol on Human Pancreatic Cancer Cells
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-29) Contribution of High-Speed In-Line Inspection to Automated and DoE-Based Development of Tablets
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-30) Comparison of Paclitaxel Distribution across CNS and PNS Barriers after Administration of Cremophor EL/Ethanol Solubilized, Albumin-Bound and Micellar Paclitaxel
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-31) Repurposing Amodiaquine as a Dry Powder Inhaled Formulation for Respiratory Disorders
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-32) Repurposing an Antiviral Peptide to Inhibit Tumor-Derived Exosomes for Synergistic Cancer Immunotherapy
Favorite
9:30 AM – 10:30 AM
ET
(W0930-05-33) Regulation of Rat Hepatic Monocarboxylate Transporter Expression by Sex and Cross-Sex Hormone Treatment
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-49) Study and Characterization of Polyurethane Mixtures to be Employed in Direct Powder Extrusion Using Expert Systems
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-50) Impact of Hot Melt Extrusion Processing on Amorphous Solid Dispersion Bulk Powder Properties
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-51) Linking 3DP Manufacturing with SIFT-MS Volatiles Organic Compound Analysis
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-52) Method Development for the Evaluation of Orally Inhaled Drug Products (OIDPs) containing Spray-Dried Phospholipid Porous Particles (PPPs)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-53) Assessment of Laser Directed Infrared Imaging for In Vitro Characterization of Pharmaceutical Tablets
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-54) Synchrotron X-Ray Diffraction of the Structure of Amorphous Indomethacin Using PDF Analysis and EPSR Modeling
Favorite
9:30 AM – 10:30 AM
ET
(W0930-08-55) Distributed Manufacturing of 3D Printed Pharmaceuticals: A Case Study
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-56) Potency Assay Development for Gene Therapy Products – Approaches and Points to Consider in Data Processing
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-57) New Insights into Non-classical Crystallization of Pharmaceutical Solids: Chemically-Specific Coherent Raman Imaging of Liquid-Liquid Phase Separation
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-58) Continuous Wet Granulation and Drying: Moving from Technical Feasibility to Commercial Scale
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-59) Pneumatic Aerosolization of the Surrogate Acetaminophen in a Newly Developed Chamber Setup for Containment Investigations with Special Focus on Spatial Dust Distribution
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-60) Mitigation of Tribocharging in Pharmaceutical Powders Using Surface Modified V-Blenders
Favorite
9:30 AM – 10:30 AM
ET
(W0930-09-61) Visualising Co-crystal Formation during Milling with Stimulated Raman Scattering (SRS)
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-63) Alternative Approach to Demonstrate Bioequivalence of Generic Formulations of Sucralfate Oral Suspension
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-64) A Science-Based Approach for Recommendation of Antagonist Blockade in the Bioequivalence Studies of Opioid Drug Products
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-65) Bioavailability and Local Immunogenicity after Subcutaneous Administration of Therapeutic Proteins: Mechanistic Modelling within the Open Systems Pharmacology Framework
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-66) Leveraging Nausea Exposure-Response Relationship to Optimize Titration and Dose Selection Decisions for Cotadutide
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-67) Utilizing PBPK Absorption Modeling to Evaluate Impact of Single-Sex on Bioequivalence Evaluation of Atorvastatin Immediate Release Tablets
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-68) Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Pantoprazole According to CYP2C19 Genetic Polymorphism
Favorite
9:30 AM – 10:30 AM
ET
(W0930-10-69) Islatravir Does Not Partition to Red Blood Cells: An In Vitro Study to Support a Total Drug Assay in Dried Blood
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-70) Assessment of Bio(in)Equivalence of Metronidazole Topical Formulations Using Stimulated Raman Scattering Microscopy
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-71) Development of Multiple Structured Pulsatile Release Tablets via Hot Melt Extrusion and Dual-Nozzle Fused Deposition Modeling 3D Printing
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-72) Investigating the Role of Critical Formulation and Process Variables Using Hybrid-Design Approach on the Redispersibility of Spray Dried Co-precipitated Nanoamorphous Micellar Dispersion
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-73) Oral Tablets Containing a Model Protein API – Impacts of Excipient Selection, API Loading, Unit Operation, and Manufacturing Process Parameters on Tablet Properties, Performance, and Stability
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-74) Synergistic Effect of Bioenhancer for Increasing the Permeation of Lopinavir via Phospholipid Complexation
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-75) Discovery and Development of Memantine Transdermal Patch
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-77) An Insight into the Interrelationship between Colloidal Stability of Protein Therapeutics in Formulation and Their Adsorption to a Solid Surface
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-78) Process Induced Degradation of Carbamazepine during Hot Melt Extrusion
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-79) Development of an Extended Release Nafamostat Formulation for Prescription Drug Overdose Protection
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-80) Stabilizing Amorphous Solid Dispersions: Polymer Blend Approach with PVP of Differing Molecular Weights
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-81) Combination Therapy for the Reversal of Multi-drug Resistant Cancer
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-82) Fabrication of Tip-Loaded Implantable PLGA Microneedles for Sustained Release of a Peptide- Carfilzomib
Favorite
9:30 AM – 10:30 AM
ET
(W0930-12-83) Effect of Methylcellulose on Suspensions Based on Various Mixing Procedures and Temperature
Favorite
9:30 AM – 10:30 AM
ET
(W0930-11-76) A Study to Assess the Gastro-Resistance and Dissolution Rate of Enteric Coated Not-Banded Gelatin and HPMC Capsules
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-01) Investigating the Relationship between Material Attributes of API and the Extent of Powder Property Enhancement via Dry Particle Coating with Nano-Silica
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-03) The Design and Assessment of Sustained Release from PLGA/PEG Blend Nanoparticles for Intravenous Application
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-05) Developing and Evaluating a Transdermal Patch of Lamotrigine for Potential Epilepsy Treatment
Favorite
10:30 AM – 11:30 AM
ET
(W1030-01-06) Felodipine Solubility Enhancement via Polymeric-Lipid Extrusion 3D Printing; Development and Stability
Favorite
10:30 AM – 11:30 AM
ET
(W1030-02-08) Characterization of In Situ Forming Implants Using CT Imaging
Favorite
10:30 AM – 11:30 AM
ET
(W1030-02-09) Development of an Artificial Intelligence-Based PBPK Model for Nanoparticles in Tumor-Bearing Mice
Favorite
10:30 AM – 11:30 AM
ET
(W1030-02-10) Evolving Component Technologies to Meet the Needs of Large Volume Injections
Favorite
10:30 AM – 11:30 AM
ET
(W1030-02-11) Injectable and Sustained Release Delivery System of Capsaicin-Loaded PLGA-Based In Situ Forming Implant for Treating Obesity: Characterization, Drug Release, and Stability Studies
Favorite
10:30 AM – 11:30 AM
ET
(W1030-02-12) Pain-Free Alternatives for Vaccinating against the Zika Virus Using 3D Printed Orally Dissolving Films (ODF) and Intranasal Drops
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-15) Controlled Release of TLR7/8 Agonist-Manganese from PLGA Microparticles for Enhanced Cancer Immunotherapy
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-16) Preparation of ZnO Nanoparticles/Doxorubicin Loaded PLLA Nanofiberous Patch for Tissue Restoration and Immunotherapy in Breast Cancer
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-18) Effect of Phospholipase A
2
(PLA
2
) Enzyme on Temozolomide Release from Composite Nanovesicles
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-19) Preformulation Study of Poloxamer 407 Formulations for Otic Delivery: The Effect Ear Stimulating Fluid (ESF) and Some Salts on Gelation Characteristics
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-20) Predicting Drug Dissolution Performance Using Molecular Dynamics Simulations
Favorite
10:30 AM – 11:30 AM
ET
(W1030-03-21) Development and In Vitro Evaluation of Eudragit-Coated Hot-Melt Extruded Ketoprofen-Pectin Pellets for Colon Targeting
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-22) Combination Therapy of Geranylgeranyl Diphosphate Synthase Inhibitor and Fatty Acid Synthase Inhibitor in Multiple Myeloma
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-23) Promising Mouse Models for Premetastatic Niche
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-24) Diethyldithiocarbamate Copper Nanoparticle Overcomes Resistance in Cancer Therapy without Inhibiting P-glycoprotein
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-25) The Estimates for the Absorption Rate Constant in Pharmacokinetics and Pharmacometrics Are Wrong: A New Era Based on the Finite Absorption Time Concept Rises
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-26) Tigecycline Pharmacokinetics after Intrapulmonary Administration in Mice
Favorite
10:30 AM – 11:30 AM
ET
(W1030-04-28) Differential Modulation of Endoplasmic Reticulum Calcium Pumps SERCA2 and SERCA3 in T Lymphocytes by Small Molecule Allosteric SERCA Activator CDN1163
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-29) Pharmacokinetics of the Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Semaglutide in Rats
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-30) Drug Delivery Optimization and Nutraceutical as Adjuvant with Antiretroviral Therapy to Suppress HIV-1 in CNS Reservoirs
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-31) Pericyte Control of Gene Expression in the Brain Endothelium: Implications for Alzheimer’s disease
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-32) Use of DEM to Troubleshoot Aesthetic Defects in Pharmaceutical Tablets
Favorite
10:30 AM – 11:30 AM
ET
(W1030-05-33) Study on the Permeability of Ophthalmic Tissues In Vitro
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-36) Novel Technical Breakthrough: qPCR with Reported LLOQ of 8 Copies / mg DNA in a 20 µL Reaction
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-38) Use of Human Plasma as a Surrogate Matrix for Quantitation of Modified Protein Therapy across Multiple Tumor Tissues
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-39) Comprehensive LC-MS/MS Analysis of VSV-GP Lipidome
Favorite
10:30 AM – 11:30 AM
ET
(W1030-06-40) Gastrointestinal Digestion and Fermentation of
Astragalus membranaceus
Polysaccharides
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-50) Development of a Gel Filtration Chromatography Method for Polyglutamic Acid in a Semisolid Dosage Form
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-51) Microdosing with Vibrating Capillary – Influence of Dosing Time on Precision
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-52) Advancing Nanocarrier Therapeutic Development with Structural AI Analysis of Cryo-EM Images
Favorite
10:30 AM – 11:30 AM
ET
(W1030-08-53) Optimized HPLC Method for the Lacosamide and Its Impurities in the Lacosamide Injection
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-56) Peptide-Based-Solutions to Reduce Undesired Cell Culture Media Chemistry – New Options for Stabilized Media Formulations
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-57) Development, Qualification, and Application of an LC-CAD-MS Method for Determination of Lipid Content in an RNA-LNP Drug Product Containing Novel Lipids with Diverse Physiochemical Properties
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-58) Challenges in Nitrosamine Determination for Pharmaceutical Products: An Analytical Perspective
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-59) A Novel High Speed NIR Sensor as a PAT Tool for Monitoring of the Tableting Process: Determination of the Effective Sampling Depth
Favorite
10:30 AM – 11:30 AM
ET
(W1030-09-60) Sensory Panel Tests for Topical Semi-solid Gels: Role of Critical Quality Attributes in Predicting Sensorial Perceptions
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-63) Atraumatic Access to Xenograft Human Glioblastoma by Cerebral Open Flow Microperfusion
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-64) 3D Bioprinted Artificial Buccal Mucosal Membranes: A Single Platform for Conducting Permeation, Efficacy and Safety Testing of Treatment Modalities for Oral Cavity Disorders
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-65) Clinical Evaluations of Potential CYP450 Inhibition by Radix Puerariae lobatae (Gegen) in Healthy Subjects
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-66) Model Development and Verification of Mechanistic Long-Acting Suspension-Based Injectable Model
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-67) Pharmacokinetics of Biologics in Obese Rats
Favorite
10:30 AM – 11:30 AM
ET
(W1030-10-68) In Vitro and In Vivo Potency of a Highly Efficient Cocaine Hydrolase and Its Long-Term Stability
Favorite
10:30 AM – 11:30 AM
ET
(W1030-11-70) Biodegradable Cationic Nanoparticles Prepared with Methylmethacrylate Copolymers Derivatives for Immune Activation and Cancer Immunotherapy
Favorite
10:30 AM – 11:30 AM
ET
(W1030-11-71) Development of Tablets with Biologics: Effect of Freeze-Dried and Spray-Dried Powders on the Compaction Behavior
Favorite
10:30 AM – 11:30 AM
ET
(W1030-11-72) Formulation and Evaluation of Carvedilol Loaded Niosomes Encapsulated in Polymeric Microneedle
Favorite
10:30 AM – 11:30 AM
ET
(W1030-11-73) Investigation of a Ternary Amorphous Solid Dispersion via Confocal Raman Spectroscopy: Where Is the Drug?
Favorite
10:30 AM – 11:30 AM
ET
(W1030-11-75) Systemic Coadministration of Selective PDE4B Inhibitor A-33 and the Pan-PPAR Agonist Lanifibranor Ameliorates Chronic Liver Disease
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-77) Application of Machine Learning to the Development of Lipid Nanoparticle
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-78) Preparation of Propolis Extract and Its In Vitro Bioactivity Enhancement by Encapsulation
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-79) In Vivo Evaluation of the Enteric Properties of Capsugel® Enprotect® Capsules in Fed State Conditions
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-80) Polymeric Excipient Selection and Their Role in Physically Stabilising Lumefantrine Amorphous Formulations
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-81) Structure-Functionality Relationship (SFR) of HPC for Solubility Enhancement: Importance of DS and MS for the HPC Hydration in Aqueous Solutions
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-82) Navigating Titanium Dioxide Free Coating Systems: Evaluating the Risk and Understanding the Alternatives
Favorite
10:30 AM – 11:30 AM
ET
(W1030-12-83) Developing Microspherical Celecoxib Amorphous Solid Dispersion Using Electrospraying for Dissolution Enhancement
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-02) Itraconazole Concentrations in the Colloidal Aqueous Phase of Contents of Upper Small Intestine after the Standard High-Calorie High-Fat Meal and Their Relevance to Itraconazole Plasma Levels
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-03) The Development of Extended-Release and Mucoadhesive Buccal Films of Adipic Acid by Hot-Melt Extrusion for Long-Term Relief of Xerostomia
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-04) Biodegradable Nanogels for Controlled Release of Artemisinin-Derived Drug to Treat Leukemia
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-05) Fibronectin (FN) Binding Efficacy of PEGylated FUD (PEG-FUD) Peptide in Bleomycin Treated Animal Model for the Treatment of Pulmonary Fibrosis
Favorite
11:30 AM – 12:30 PM
ET
(W1130-01-06) Development and Characterization of Ciprofloxacin Nanoemulsion-Loaded Bigels of Different Oleogel to Hydrogel Ratios: A Comparative Study
Favorite
11:30 AM – 12:30 PM
ET
(W1130-02-08) Colestipol Hydrochloride Tablets: Challenges of Formulating a Complex Active Pharmaceutical Ingredient and Product Quality Considerations
Favorite
11:30 AM – 12:30 PM
ET
(W1130-02-09) Development of Polymeric Nanoparticles for Targeted Follicular Delivery of Tazarotene for Treatment of Inflammatory Skin Conditions
Favorite
11:30 AM – 12:30 PM
ET
(W1130-02-10) Excipient Enhanced Growth (EEG) Synthetic Lung Surfactant Powder Formulation for Treating Neonatal Respiratory Distress Syndrome (NRDS)
Favorite
11:30 AM – 12:30 PM
ET
(W1130-02-11) Interaction between Different Types of Excipients and Protein
Favorite
11:30 AM – 12:30 PM
ET
(W1130-02-12) Polydopamine-Coated Nanoparticles as a Targeted Drug Delivery System for the Treatment of
Helicobacter pylori
-Infected Gastric Ulcer
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-15) On-Demand Multi-Indication Fast-Dissolving Inserts (FDIs) for Birth Control and HIV Prevention
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-16) Design, Physicochemical Characterization and In Vitro Cytotoxicity of Cisplatin-Loaded PEGylated Chitosan Injectable Nano / Sub-micron Crystals
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-17) Effect of Bioadhesive Polymer Hydration on Mucociliary Clearance
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-18) Formulation and Development of Rivastigmine tartrate Sustained-Release Tablets
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-19) Optimization of Process Parameters for Apixaban Long-Acting Parental PLGA Microspheres
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-20) Additive Manufacturing via Laser Sintering: Assessing the Influence of Parameter Selection on Printing Performance
Favorite
11:30 AM – 12:30 PM
ET
(W1130-03-21) Perforated Pan Coating of Directly Compressed Minitablets with the Use of Multi-tip Tooling to Facilitate Multi-particulate Drug Delivery: Challenges and Outcomes
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-22) Valproic Acid Elevates HIF-1α-mediated
CGB
Expression and Suppresses Glucose Uptake in BeWo Cells
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-23) Synthesis, Conformational Analysis, and Binding Studies of 6α-mannobiose Glycosides
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-24) Mebendazole Nanosuspension for the Treatment of Glioblastoma
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-25) Software-Optimized Oligonucleotide Purification with Preparative HPLC/MS
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-26) Peonidin-3-O-Glucoside and Resveratrol Reduce Human hFOB Osteoblast Apoptosis and Alter the Expression of Genes Associated with Apoptosis, Differentiation and Osteoclastogenesis
Favorite
11:30 AM – 12:30 PM
ET
(W1130-04-27) The Effect of MO-OH-Nap Tropolone on Osteosarcoma Cellular Metabolism
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-36) Understanding Synthetic High-Density Lipoprotein Remodeling Ex Vivo Using Human Serum
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-37) Validation of an In Vitro Cell-Based Assay for the Detection of Neutralizing Antibodies against Adeno-Associated Virus 9 in Cynomolgus Monkey
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-38) Utilizing Organic Solvents for Residual Solvent and Volatile Impurity Analysis of Water-Insoluble Articles Using SIFT-MS
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-39) Bioanalysis of Endonuclease Cas9 in Plasma Conducing to Clarify CRISPR-Cas9-Mediated Genome Engineering Using Immunocapture followed with LC-MS/MS Screener Application
Favorite
11:30 AM – 12:30 PM
ET
(W1130-06-40) Validating Digital Droplet PCR (ddPCR) Assay with Zero-Inflated Poisson Model
Favorite
11:30 AM – 12:30 PM
ET
(W1130-08-49) In Line Particle Size Detection in Roll Compaction
Favorite
11:30 AM – 12:30 PM
ET
(W1130-08-51) Impact of Microcrystalline Cellulose Particle Size Grade on Loss-in-Weight Continuous Feeding
Favorite
11:30 AM – 12:30 PM
ET
(W1130-08-52) Development of Nano Albumin Bound (nab) Paclitaxel Using Scalable High Shear Processing Technology and Comparison of Plasma-Derived and Recombinant Human Serum Albumin
Favorite
11:30 AM – 12:30 PM
ET
(W1130-08-53) Impact of Lyoprotectant Thermal Properties on Batch Heterogeneity through Various Processing Technologies: Annealing vs. Controlled Ice Nucleation
Favorite
11:30 AM – 12:30 PM
ET
(W1130-09-56) Investigating Stability of Trastuzumab (Herzuma
®
) Undergoing Lyophilization and Freeze-Thaw Stresses
Favorite
11:30 AM – 12:30 PM
ET
(W1130-09-57) Re-Development of a Fit-for-Purpose Assay Degradation HPLC Method Using Open Lab Software
Favorite
11:30 AM – 12:30 PM
ET
(W1130-09-58) Qualitative and Quantitative Analysis of Lipids in Exparel
®
Injectable Liposomal Drug Formulation
Favorite
11:30 AM – 12:30 PM
ET
(W1130-09-59) Predicting Tablet Cascade of ConsiGma Continuous Coater Using Discrete-Element-Method (DEM) Simulations
Favorite
11:30 AM – 12:30 PM
ET
(W1130-09-60) Temporal Dominance Sensations (TDS) for Topical Skin Products
Favorite
11:30 AM – 12:30 PM
ET
(W1130-09-61) Low Dose Formulations in Continuous Manufacturing of Tablets via Semi-continuous Feeding and Blending
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-63) Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict the Pharmacokinetics of Pitavastatin in Different SLCO1B1 Diplotypes
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-64) Refining Predictions of Food Effects on Drug Absorption: Models Predicting Gastric Emptying and Bile Concentrations Based on Fat Content and Caloric Intake
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-65) Development and Validation of a Physiologically Based Pharmacokinetic Model of Tofacitinib in Mice to Predict Dosing in Higher Animal Species
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-66) Multiscale Modeling-Identified Synergistic Combinations of Anti-microRNA-155 and Standard-of-Care Drugs for Improved Outcomes in Non-small Cell Lung Cancer
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-67) Effects of Abcb1 and Abcg2 on the Brain Penetration, Biliary Disposition, and Intestinal Secretion of the PI3K Inhibitor Taselisib
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-68) Development of Stable Flocculated Suspension Formulation for Preclinical Studies
Favorite
11:30 AM – 12:30 PM
ET
(W1130-10-69) Pharmacokinetics, Excretion, and Metabolism of [
14
C]Aficamten Following Single Oral Dose Administration to Rats
Favorite
11:30 AM – 12:30 PM
ET
(W1130-11-70) Fabrication of Suppository Shells via Hot-Melt Extrusion Paired with Fused Deposition Modeling (FDM) 3D Printing Techniques
Favorite
11:30 AM – 12:30 PM
ET
(W1130-11-71) Characterization of 3D Printable Hydrogel-Inks for Cardiovascular Implants
Favorite
11:30 AM – 12:30 PM
ET
(W1130-11-72) Formulation Development and Evaluation of Cannabidiol Hot Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications
Favorite
11:30 AM – 12:30 PM
ET
(W1130-11-73) IR-820 Dye-Based Layer-by-Layer Inhalation System as a Theranostic Agent for Non-invasive NIRF Imaging of Tumor Margins in Lung Cancers
Favorite
11:30 AM – 12:30 PM
ET
(W1130-11-74) Pre-clinical and Clinical Evaluation of a Weekly Donepezil Transdermal Patch
Favorite
11:30 AM – 12:30 PM
ET
(W1130-11-75) Tailoring Ligand-Altered Nanostructured Lipid Carrier for the Brain Delivery of Anti-cancer Drug cum herbal Compound for the Treatment of Glioblastoma Multiforme
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-78) Unlocking Residuals: Shelf-Life Predication for Oral Tablets Using Moisture-Modified Arrhenius Modeling
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-79) Personalisation of Data Matrix Encoded Hydrocortisone Orodispersible Films Using Inkjet Printing
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-80) Effect of Particle Size on the In Vitro/In Vivo Evaluation of Long-Acting Injectable Paliperidone Palmitate Suspension
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-81) Curcumin Nanocrystals-in-Nanofibers as a Promising Platform for the Management of Periodontal Disease
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-82) Mechanistic Modeling of Intramuscular Administration of Long-Acting Injectable Suspensions Accounting for Fibrosis at the Depot Site
Favorite
11:30 AM – 12:30 PM
ET
(W1130-12-83) Exploring the Mechanism of Mechanochemically Induced Cocrystal Formation with Terahertz Spectroscopy
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-02) Liposome-Based Dissolving Microneedles Loaded with Rifampicin for Improved Treatment of MRSA-Induced Skin Infection
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-04) Development of a Novel Polymeric Composite Film and Elucidation of Its New Alcohol-Resistant Mechanisms for the Prevention of Alcohol-Induced Dose Dumping
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-05) Brain Targeted Delivery of Cannabidiol and Brain Derived Neurotrophic Factor (BDNF) for Attenuation of Inflammation and Promotion of Neurogenesis for the Management of Alzheimer’s disease
Favorite
12:30 PM – 1:30 PM
ET
(W1230-01-06) Fibronectin-Targeted Dendron Micelles to Effectively Deliver BRD4-Inhibitors for Inflammation Reduction in an Idiopathic Pulmonary Fibrosis Model
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-08) Colorectal Lumen-to-Tumor Delivery of Rectally Administered Ligand-Functionalized Nanoparticles for the Local Treatment of Colorectal Cancer
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-09) Development of Rapidly Soluble Mebendazole Nanosuspension for Colorectal Cancer
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-10) Exploring Dual Centrifuge Wet Media Milling Process as an Organic Solvent Free Method to Prepare Liposomes with High Drug Loading
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-11) Intestinal Delivery of Live Biotherapeutic Products by pH-Sustaining Hydrogels and Their Therapeutic Efficacies on DSS-Induced Colitis
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-12) Polymorphism and Solvatomorphism of Niclosamide-Camostat Cocrystals and Bioavailability Enhancement of Low-Solubility API via Co-Crystallization
Favorite
12:30 PM – 1:30 PM
ET
(W1230-02-13) Studying Drug Release in Multilayered Polymer-Drug Formulations for Oral Delivery
Favorite
12:30 PM – 1:30 PM
ET
(W1230-03-15) Development of Aerosolizable mRNA Incorporated Chitosan Nanoparticles for Efficient Lung Delivery
Favorite
12:30 PM – 1:30 PM
ET
(W1230-03-17) Minoxidil Foaming Topical Formulation without Propellant and Inhibition of Crystalline Formation
Favorite
12:30 PM – 1:30 PM
ET
(W1230-03-18) Stimuli-Responsive Newly Designed Poly (amino ether) Glycopolymer Based Pegylated Nanoparticles Conjugated with Receptor Binding Peptide for siRNA Delivery to Treat Lung Cancer
Favorite
12:30 PM – 1:30 PM
ET
(W1230-03-19) Characteristic and Bio-Functionality of a Novel Multilayered Crosslinked Nanoscaffold for Tuberculosis Granuloma Modelling
Favorite
12:30 PM – 1:30 PM
ET
(W1230-03-20) Development of a Novel, Semi-mechanistic In Vitro Dissolution Model to Inform Physiology-Based Biopharmaceutics Modeling Frameworks
Favorite
12:30 PM – 1:30 PM
ET
(W1230-03-21) Fabrication of Bio-Adhesive Gastric Floating Pellets Using Hot-Melt Extrusion
Favorite
12:30 PM – 1:30 PM
ET
(W1230-06-36) LC-MS/MS Method Development and Validation for Quantitative Analysis of CART Peptides in Cell Culture Supernatant and Human Plasma
Favorite
12:30 PM – 1:30 PM
ET
(W1230-06-37) PD-L1 Gene Expression Quantification in Single Cell on Tissue for Accurately Predicting Response to ICIs
Favorite
12:30 PM – 1:30 PM
ET
(W1230-06-38) Measuring Free IgE in Low-Affinity Interaction with Omalizumab Using an Automated Microfluidic Immunoassay to Support Pharmacokinetics and Pharmacodynamics Studies
Favorite
12:30 PM – 1:30 PM
ET
(W1230-06-39) Simultaneous LC-MS/MS Method for the Quantitation of Azithromycin, Hydroxychloroquine and its Metabolites In SARS-CoV-2(-/+) Populations Using Dried Blood Spots
Favorite
12:30 PM – 1:30 PM
ET
(W1230-10-63) Clarifying the Impact of Advanced Age on the Physicochemical Characteristics of Gastric Contents in the Fasted State
Favorite
12:30 PM – 1:30 PM
ET
(W1230-10-64) COG133-Targeted Polymeric Nanoparticles Encapsulating PLK-1 Inhibitor Blocks DNA-Damage Repair Pathways to Sensitize Medulloblastoma Cells for Radiotherapy
Favorite
12:30 PM – 1:30 PM
ET
(W1230-10-66) A Novel Approach to Harvest Human Mucus on RepliGut® Planar Platform for Research Related to Gastrointestinal Tract and Its Associated Disorders, along with Drug Delivery Studies
Favorite
12:30 PM – 1:30 PM
ET
(W1230-10-67) Development of In Vitro In Vivo Correlation for Establishing Clinically Relevant Dissolution Specifications of Lamotrigine ER Tablets
Favorite
12:30 PM – 1:30 PM
ET
(W1230-10-68) A Phase 1, Open-Label, Single-Period, Nonrandomized Study of the Pharmacokinetics, Excretion, Mass Balance and Metabolism of Oral [
14
C] PF-07265803 (ARRY-371797) in Healthy Male Adults
Favorite
12:30 PM – 1:30 PM
ET
(W1230-11-70) Characterization of a New Multifunctional Disintegrant for Continuous Manufacturing
Favorite
12:30 PM – 1:30 PM
ET
(W1230-11-72) Formulation Development of Programmable Drug Delivery Multi-Unit Systems for the Delayed and Extended Release of Fixed Dose Combination Drugs
Favorite
12:30 PM – 1:30 PM
ET
(W1230-11-73) Lipid Nanoparticles versus Lipoplexes: Optimizing Complexing Head Group and Formulation Technology for Efficient Gene Delivery
Favorite
12:30 PM – 1:30 PM
ET
(W1230-11-74) Predicting Stability of Lyophilized mRNA/LNP Formulations Using Solid State NMR
Favorite
12:30 PM – 1:30 PM
ET
(W1230-11-75) The Application of Machine Learning in Predicting Bioink Printability
Favorite
12:30 PM – 1:30 PM
ET
(W1230-11-71) Dissolving Microneedle Patches for Enhanced Melanoma Ferroptosis Therapy Based on a Lipophagy-Fueled Strategy
Favorite
